Article Details
Retrieved on: 2022-08-15 12:10:51
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Q32 Bio's lead programs, focused on the IL-7 / TSLP receptor pathways and complement system, address immune dysregulation to help patients take ...
Article found on: www.bakersfield.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here